Now Enrolling People with Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) For A Research Study.

by admin | Apr 19, 2024 | Article

Now Enrolling People with Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) For A Research Study Study Title:Phase 2 ALXN1210-NEPH-202 Study (clinicaltrials.gov NCT04564339) Study Sponsor:Alexion, Astra Zeneca Rare Disease Purpose of Study:The purpose of...

COVID-19 VACCINE ROLLOUT

by admin | Apr 19, 2024 | Article

As provincial governments begin their rollout plans for the COVID-19 vaccine we encourage you to speak with your healthcare team or...

AZD1222 US Phase III trial met primary efficacy endpoint in preventing COVID-19 at interim analysis

by admin | Apr 19, 2024 | Article

https://www.lupuscanada.org/wp-content/uploads/AZD1222_PhIII-US-HLR_RNS.pdf

Dr. Samir Gupta explains how the four COVID-19 vaccines now approved in Canada work and why efficacy rates aren’t the most important number to look at.

by admin | Apr 19, 2024 | Article

https://www.cbc.ca/player/play/1880969283645

Six Bio-Ethicists on Ontario Government’s “Bioethics Table” Confirm Ongoing Concerns Raised by Disability Organizations regarding the Discriminatory and Secret Plans for the Triaging of Critical Care

by admin | Apr 19, 2024 | Article

https://archdisabilitylaw.ca/news-release-for-immediate-release-six-bio-ethicists-on-ontario-governments-bioethics-table-confirm-ongoing-concerns-raised-by-disability-organizations-regarding-the-dis